Patients, clinicians and researchers have much to thank John A. Thompson, MD, for when he retires at the end of 2024 after 40 ...

Immune checkpoint inhibitors (ICIs) have shown significant promise in treating tumors. Immune checkpoint inhibitors are a form of immunotherapy, which redi | Immunology ...

The impact of metformin on progression-free survival following immune checkpoint inhibitors in overweight (n = 284 ... tumor ...

According to Exactitude Consultancy, the Cancer Immunotherapy Market is expected to expand ... patients’ immune systems to help make commonly used chemotherapies and checkpoint inhibitors, such as ...

See how Checkpoint Therapeutics, Inc.'s FDA-approved Unloxcyt drug for cSCC is set to disrupt the market with innovative ...

Cancer immunotherapy has revolutionized the treatment landscape for various malignancies, offering new hope for patients. However, recent evidence has highlighted significant sex disparities in the ...

Immunotherapies have become a cornerstone in cancer treatment, with current therapies like checkpoint inhibitors enhancing ...

SAN DIEGO and CALGARY, AB, Dec. 18, 2024 /CNW/ -- Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy ... commonly used chemotherapies ...

Northwestern Medicine scientists have developed a method for identifying reactive cysteines on peptide antigens within the ...

CTLA-4 inhibitors are a well-established market in cancer care, and they are expected to grow significantly in the coming ...

New treatments and adverse events impacting patient quality of life were among the topics of interest in 2024.

Antibody-drug conjugates (ADCs) represent a promising cancer treatment modality designed to deliver highly potent cytotoxic ...